Literature DB >> 31245322

Challenging Implantation of Hip Prosthesis in a 32-year-old Patient with Kniest Syndrome.

Philipp Krenn1, Sebastian Gehmert2, Andreas H Krieg2, Andrej M Nowakowski3,4.   

Abstract

INTRODUCTION: Kniest dysplasia is associated with short body stature (dwarfism) and impairment of the musculoskeletal system due to a mutation in the COL2A1 gene coding for a protein that forms type II collagen. Hip endoprosthesis for patients with Kniest system requires a specific femoral shaft design since the medullar space is limited due to the underlying dysplasia. The Wagner cone stem has shown excellent results. It is especially suitable for patients with small or dysplasic femur. However, no data exist regarding hip endoprosthesis in a patient with Kniest syndrome. CASE REPORT: A 32-year-old female patient with Kniest syndrome presented at our department with a painful pseudarthrosis after femoral valgisation osteotomy 8 years ago. A Wagner cone stem and acetabular roof cup with a cemented Ecofit cup 2M (dual-articulation acetabular cup system) were implanted due to a dysplastic femur with a small medullary space. The Ecofit cup itself is associated with a reduced risk of dislocation. The patient was satisfied with the range of motion after hip endoprosthesis and reported a significant increase in quality of life. The patient is still comfortable with the hip prosthesis at the most recent follow-up 4 years after implantation. Follow-up radiographs over 4 years have not revealed any signs of loosening or migration, and no Trendelenburg sign was reported for the affected side.
CONCLUSION: The Wagner cone stem provides a good solution in challenging femora caused by previous osteotomies, fractures, or dysplasia. Additional stability of hip prosthesis can be achieved using a dual articulation acetabular cup system. Furthermore, we applied an attachment tube based on the concept of tumorprosthesis where the abductor muscle group got reattached.

Entities:  

Keywords:  Dual articulation acetabular cup system; Kniest syndrome; Wagner cone stem

Year:  2019        PMID: 31245322      PMCID: PMC6588156          DOI: 10.13107/jocr.2250-0685.1310

Source DB:  PubMed          Journal:  J Orthop Case Rep        ISSN: 2250-0685


  7 in total

1.  Long-term results of the Wagner cone prosthesis.

Authors:  Alexander Schuh; Annemarie Schraml; Gerd Hohenberger
Journal:  Int Orthop       Date:  2007-10-12       Impact factor: 3.075

2.  The use of a dual-articulation acetabular cup system to prevent dislocation after primary total hip arthroplasty: analysis of 384 cases at a mean follow-up of 15 years.

Authors:  Remi Philippot; Jean Philippe Camilleri; Bertrand Boyer; Philippe Adam; Frederic Farizon
Journal:  Int Orthop       Date:  2008-06-03       Impact factor: 3.075

3.  Surgery of the head and neck in patient with Kniest dysplasia: Is wound healing an issue?

Authors:  Qasim Husain; Jungsuk Cho; Jay Neugarten; Vikash K Modi
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2016-12-26       Impact factor: 1.675

4.  The Wagner Cone Stem for the Management of the Challenging Femur in Primary Hip Arthroplasty.

Authors:  Michael C Parry; Mihai H Vioreanu; Donald S Garbuz; Bassam A Masri; Clive P Duncan
Journal:  J Arthroplasty       Date:  2016-02-17       Impact factor: 4.757

5.  Total hip replacement with an uncemented Wagner cone stem for patients with congenital hip dysplasia.

Authors:  Raúl Torres Claramunt; Fernando Marqués; Alfonso León; Gemma Vilà; Carlos Mestre; Lluís Puig Verdié
Journal:  Int Orthop       Date:  2011-02-12       Impact factor: 3.075

6.  Bilateral total hip arthroplasty in subjects with multiple epiphyseal dysplasia.

Authors:  Vito Pavone; Luciano Costarella; Vincenzo Privitera; Giuseppe Sessa
Journal:  J Arthroplasty       Date:  2008-09-11       Impact factor: 4.757

7.  Excellent long-term results of the Müller acetabular reinforcement ring in primary cup revision.

Authors:  Pascal Mueller Greber; Isabella Manzoni; Peter E Ochsner; Thomas Ilchmann; Lukas Zwicky; Martin Clauss
Journal:  Acta Orthop       Date:  2017-08-03       Impact factor: 3.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.